The role of multiparametric MRI in biopsy-naive prostate cancer
Nature Reviews Urology
© 2019, US Government. Results of recent trials have shown the superiority of mpMRI to TRUS-guided systematic biopsy for detecting clinically significant prostate cancer. However, only performing an mpMRI risks missing MRI-invisible lesions and, therefore, there might be added value in performing both targeted and systematic biopsies in biopsy-naive patients.
Lebastchi, A., & Pinto, P. (2019). The role of multiparametric MRI in biopsy-naive prostate cancer. Nature Reviews Urology, 16 (5). http://dx.doi.org/10.1038/s41585-019-0173-7